Human melanoma: development and progression - PubMed (original) (raw)
Review
Human melanoma: development and progression
M Herlyn. Cancer Metastasis Rev. 1990 Sep.
Abstract
Clinical and histopathological evidence suggests that melanoma develops in a sequence of steps, progressing from benign proliferative lesions, to primary melanomas that do not show evidence for metastasis, to invasive primary lesions, and to metastases. This review focuses on the experimental studies examining the phenotypic characteristics of cultured primary melanoma cells as they relate to cells from non-malignant nevi and metastases. Genetic, biologic, and immunologic criteria have been established to distinguish melanocytes from different steps of tumor development. These include non-random chromosomal abnormalities, expression of melanocyte- and melanoma-specific antigens, requirements for exogenous growth factors, production of endogenous growth factors, and expression of receptors for growth factors. The transformation of melanocytes and nevus cells with viral oncogenes has facilitated studies on the malignant phenotype. Variants have been developed through successive selections from primary melanoma cell populations that have one or several characteristics of metastatic cells. The study of melanocytes isolated from various stages of tumor development and the generation of cell variants with specific properties should enable a long-term search for the molecular mechanisms of melanoma development and progression.
Similar articles
- Tumor progression in the human melanocytic system.
Kath R, Rodeck U, Menssen HD, Mancianti ML, Linnenbach AJ, Elder DE, Herlyn M. Kath R, et al. Anticancer Res. 1989 Jul-Aug;9(4):865-72. Anticancer Res. 1989. PMID: 2554787 - A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L. Boukerche H, et al. Cancer Res. 2000 Oct 15;60(20):5848-56. Cancer Res. 2000. PMID: 11059782 - Tumor progression in melanoma: the biology of epidermal melanocytes in vitro.
Mancianti ML, Herlyn M. Mancianti ML, et al. Carcinog Compr Surv. 1989;11:369-86. Carcinog Compr Surv. 1989. PMID: 2646021 Review. - Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH, et al. Herlyn M, et al. Cancer Res. 1985 Nov;45(11 Pt 2):5670-6. Cancer Res. 1985. PMID: 4053039 - Biology of tumor progression in human melanocytes.
Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Herlyn M, et al. Lab Invest. 1987 May;56(5):461-74. Lab Invest. 1987. PMID: 3553733 Review.
Cited by
- Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Luca M, et al. Am J Pathol. 1997 Oct;151(4):1105-13. Am J Pathol. 1997. PMID: 9327744 Free PMC article. - Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.
Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM. Engesæter B, et al. PLoS One. 2012;7(9):e45492. doi: 10.1371/journal.pone.0045492. Epub 2012 Sep 20. PLoS One. 2012. PMID: 23029050 Free PMC article. - Quantitative analysis of tumour spheroid structure.
Browning AP, Sharp JA, Murphy RJ, Gunasingh G, Lawson B, Burrage K, Haass NK, Simpson M. Browning AP, et al. Elife. 2021 Nov 29;10:e73020. doi: 10.7554/eLife.73020. Elife. 2021. PMID: 34842141 Free PMC article. - Malignant progression of B16 melanoma cells induced in vitro by growth factors produced by highly malignant cells.
Stackpole CW, Groszek L, Kalbag SS. Stackpole CW, et al. Clin Exp Metastasis. 1995 Mar;13(2):105-15. doi: 10.1007/BF00133615. Clin Exp Metastasis. 1995. PMID: 7882613
References
- J Cell Sci. 1985 Aug;77:167-83 - PubMed
- J Natl Cancer Inst. 1989 Dec 20;81(24):1893-904 - PubMed
- J Natl Cancer Inst. 1985 Feb;74(2):283-9 - PubMed
- J Exp Med. 1982 Dec 1;156(6):1755-66 - PubMed
- Oncogene Res. 1988 Sep;3(2):177-86 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials